Stool Transplants to Treat Refractory Clostridium Difficile Colitis | MicrobiomeTrials← Back to trialsNCT02127398
Stool Transplants to Treat Refractory Clostridium Difficile Colitis
RecruitingPHASE2INTERVENTIONAL
Trial Details
Start: 2016-04Est. Completion: 2027-05
Enrollment target: 77 participants Locations- Duke University Medical Center, Durham, North Carolina, United States
Other microbiome trials you might be interested in
Blood PressureIntraoperative HypotensionPostoperative ComplicationsSurgeryAnesthesia
Rates of major complications and mortality in the first weeks after surgery remain very high: postoperative mortality is…
Hamburg, GermanyCompleted May 25, 2024
DysbiosisClostridium DifficilePet-Human BondingAntibiotic-Associated Colitis
Antimicrobial therapy can lead to disruption of the gut microbiome and infection with Clostridioides difficile, a diseas…
Philadelphia, United States
Est. completion Sep 1, 2026
Ulcerative Colitis (UC)Inflammatory Bowel Disease (IBD)Colitis
This Phase 2b randomized, double-blind, placebo-controlled, multicenter trial will evaluate the efficacy and safety of a…
Izmir, Turkey (Türkiye)Est. completion Dec 30, 2027